Drug Interactions
Comprehensive guide to drug-drug interactions, pharmacokinetic interactions, and interaction management.
Browse the pages below for detailed information.
glycopyrrolate — M5 receptor Interaction
Drug-target interaction between glycopyrrolate and M5 receptor. Synthetic organic pharmacological agent targeting this protein.
goserelin — GnRH1 receptor Interaction
Drug-target interaction between goserelin and GnRH1 receptor. Peptide pharmacological agent targeting this protein.
granisetron — 5-HT3A Interaction
Drug-target interaction between granisetron and 5-HT3A. Synthetic organic pharmacological agent targeting this protein.
growth hormone 1 — Growth hormone receptor Interaction
Drug-target interaction between growth hormone 1 and Growth hormone receptor. Peptide pharmacological agent targeting this protein.
guanabenz — α2A-adrenoceptor Interaction
Drug-target interaction between guanabenz and α2A-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
guanabenz — α2B-adrenoceptor Interaction
Drug-target interaction between guanabenz and α2B-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
guanabenz — α2C-adrenoceptor Interaction
Drug-target interaction between guanabenz and α2C-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
guanfacine — α2A-adrenoceptor Interaction
Drug-target interaction between guanfacine and α2A-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
guanfacine — α2B-adrenoceptor Interaction
Drug-target interaction between guanfacine and α2B-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
guanfacine — α2C-adrenoceptor Interaction
Drug-target interaction between guanfacine and α2C-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
haloperidol — 5-HT2A receptor Interaction
Drug-target interaction between haloperidol and 5-HT2A receptor. Synthetic organic pharmacological agent targeting this protein.
haloperidol — D2 receptor Interaction
Drug-target interaction between haloperidol and D2 receptor. Synthetic organic pharmacological agent targeting this protein.
haloperidol — D3 receptor Interaction
Drug-target interaction between haloperidol and D3 receptor. Synthetic organic pharmacological agent targeting this protein.
haloperidol — D4 receptor Interaction
Drug-target interaction between haloperidol and D4 receptor. Synthetic organic pharmacological agent targeting this protein.
halothane — K2P10.1 Interaction
Drug-target interaction between halothane and K2P10.1. Synthetic organic pharmacological agent targeting this protein.
halothane — K2P9.1 Interaction
Drug-target interaction between halothane and K2P9.1. Synthetic organic pharmacological agent targeting this protein.
heparin — serpin family C member 1 Interaction
Drug-target interaction between heparin and serpin family C member 1. Metabolite pharmacological agent targeting this protein.
hydrochlorothiazide — Na-Cl symporter Interaction
Drug-target interaction between hydrochlorothiazide and Na-Cl symporter. Synthetic organic pharmacological agent targeting this protein.
hydrocodone — μ receptor Interaction
Drug-target interaction between hydrocodone and μ receptor. Synthetic organic pharmacological agent targeting this protein.
hydromorphone — μ receptor Interaction
Drug-target interaction between hydromorphone and μ receptor. Synthetic organic pharmacological agent targeting this protein.
hydroxychloroquine — TLR7 Interaction
Drug-target interaction between hydroxychloroquine and TLR7. Synthetic organic pharmacological agent targeting this protein.
hydroxychloroquine — TLR9 Interaction
Drug-target interaction between hydroxychloroquine and TLR9. Synthetic organic pharmacological agent targeting this protein.
hydroxyurea — ribonucleotide reductase catalytic subunit M1 Interaction
Drug-target interaction between hydroxyurea and ribonucleotide reductase catalytic subunit M1. Synthetic organic pharmacological agent targeting this protein.
hydroxyurea — ribonucleotide reductase regulatory subunit M2 Interaction
Drug-target interaction between hydroxyurea and ribonucleotide reductase regulatory subunit M2. Synthetic organic pharmacological agent targeting this protein.
hydroxyzine — H1 receptor Interaction
Drug-target interaction between hydroxyzine and H1 receptor. Synthetic organic pharmacological agent targeting this protein.
ibalizumab — CD4 Interaction
Drug-target interaction between ibalizumab and CD4. Antibody pharmacological agent targeting this protein.
ibandronic acid — farnesyl diphosphate synthase Interaction
Drug-target interaction between ibandronic acid and farnesyl diphosphate synthase. Synthetic organic pharmacological agent targeting this protein.
ibritumomab tiuxetan — CD20 (membrane-spanning 4-domains, subfamily A, member 1) Interaction
Drug-target interaction between ibritumomab tiuxetan and CD20 (membrane-spanning 4-domains, subfamily A, member 1). Antibody pharmacological agent targeting this protein.
ibrutinib — Bruton tyrosine kinase Interaction
Drug-target interaction between ibrutinib and Bruton tyrosine kinase. Synthetic organic pharmacological agent targeting this protein.
ibudilast — phosphodiesterase 4A Interaction
Drug-target interaction between ibudilast and phosphodiesterase 4A. Synthetic organic pharmacological agent targeting this protein.
ibudilast — phosphodiesterase 4B Interaction
Drug-target interaction between ibudilast and phosphodiesterase 4B. Synthetic organic pharmacological agent targeting this protein.
ibudilast — phosphodiesterase 4C Interaction
Drug-target interaction between ibudilast and phosphodiesterase 4C. Synthetic organic pharmacological agent targeting this protein.
ibuprofen — COX-1 Interaction
Drug-target interaction between ibuprofen and COX-1. Synthetic organic pharmacological agent targeting this protein.
ibuprofen — COX-2 Interaction
Drug-target interaction between ibuprofen and COX-2. Synthetic organic pharmacological agent targeting this protein.
ibutilide — Kv11.1 Interaction
Drug-target interaction between ibutilide and Kv11.1. Synthetic organic pharmacological agent targeting this protein.
icatibant — B2 receptor Interaction
Drug-target interaction between icatibant and B2 receptor. Peptide pharmacological agent targeting this protein.
icotinib — epidermal growth factor receptor Interaction
Drug-target interaction between icotinib and epidermal growth factor receptor. Synthetic organic pharmacological agent targeting this protein.
icotrokinra — Interleukin-23 receptor Interaction
Drug-target interaction between icotrokinra and Interleukin-23 receptor. Peptide pharmacological agent targeting this protein.
idelalisib — phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta Interaction
Drug-target interaction between idelalisib and phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta. Synthetic organic pharmacological agent targeting this protein.
ifupinostat — phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha Interaction
Drug-target interaction between ifupinostat and phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha. Synthetic organic pharmacological agent targeting this protein.
iloprost — IP receptor Interaction
Drug-target interaction between iloprost and IP receptor. Synthetic organic pharmacological agent targeting this protein.
imatinib — ABL proto-oncogene 1, non-receptor tyrosine kinase Interaction
Drug-target interaction between imatinib and ABL proto-oncogene 1, non-receptor tyrosine kinase. Synthetic organic pharmacological agent targeting this protein.
imidapril — Angiotensin-converting enzyme Interaction
Drug-target interaction between imidapril and Angiotensin-converting enzyme. Synthetic organic pharmacological agent targeting this protein.
imidaprilat — Angiotensin-converting enzyme Interaction
Drug-target interaction between imidaprilat and Angiotensin-converting enzyme. Synthetic organic pharmacological agent targeting this protein.
imipramine — NET Interaction
Drug-target interaction between imipramine and NET. Synthetic organic pharmacological agent targeting this protein.
imipramine — SERT Interaction
Drug-target interaction between imipramine and SERT. Synthetic organic pharmacological agent targeting this protein.
imiquimod — TLR7 Interaction
Drug-target interaction between imiquimod and TLR7. Synthetic organic pharmacological agent targeting this protein.
inamrinone — phosphodiesterase 3A Interaction
Drug-target interaction between inamrinone and phosphodiesterase 3A. Synthetic organic pharmacological agent targeting this protein.
inamrinone — phosphodiesterase 3B Interaction
Drug-target interaction between inamrinone and phosphodiesterase 3B. Synthetic organic pharmacological agent targeting this protein.
inavolisib — phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha Interaction
Drug-target interaction between inavolisib and phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha. Synthetic organic pharmacological agent targeting this protein.
indacaterol — β2-adrenoceptor Interaction
Drug-target interaction between indacaterol and β2-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
inebilizumab — CD19 Interaction
Drug-target interaction between inebilizumab and CD19. Antibody pharmacological agent targeting this protein.
infigratinib — fibroblast growth factor receptor 1 Interaction
Drug-target interaction between infigratinib and fibroblast growth factor receptor 1. Synthetic organic pharmacological agent targeting this protein.
infigratinib — fibroblast growth factor receptor 2 Interaction
Drug-target interaction between infigratinib and fibroblast growth factor receptor 2. Synthetic organic pharmacological agent targeting this protein.
infigratinib — fibroblast growth factor receptor 3 Interaction
Drug-target interaction between infigratinib and fibroblast growth factor receptor 3. Synthetic organic pharmacological agent targeting this protein.
ingenol mebutate — protein kinase C delta Interaction
Drug-target interaction between ingenol mebutate and protein kinase C delta. Natural product pharmacological agent targeting this protein.
inotuzumab ozogamicin — CD22 Interaction
Drug-target interaction between inotuzumab ozogamicin and CD22. Antibody pharmacological agent targeting this protein.
insulin — Insulin receptor Interaction
Drug-target interaction between insulin and Insulin receptor. Peptide pharmacological agent targeting this protein.
iparomlimab — programmed cell death 1 (CD279) Interaction
Drug-target interaction between iparomlimab and programmed cell death 1 (CD279). Antibody pharmacological agent targeting this protein.
ipilimumab — cytotoxic T-lymphocyte-associated protein 4 (CD152) Interaction
Drug-target interaction between ipilimumab and cytotoxic T-lymphocyte-associated protein 4 (CD152). Antibody pharmacological agent targeting this protein.